Modulation of Factor 11 expression

Details for Australian Patent Application No. 2009305636 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Freier, Susan M.; Monia, Brett P.; Zhang, Hong; Zhao, Chenguang; Crosby, Jeffrey R.; Siwkowski, Andrew M.

Agent Davies Collison Cave

Pub. Number AU-A-2009305636

PCT Pub. Number WO2010/045509

Priority 61/105,772 15.10.08 US; 61/174,461 30.04.09 US

Filing date 15 October 2009

Wipo publication date 22 April 2010

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/045509 Priority application(s): WO2010/045509

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009305639-Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics

2009305625-Prosthetic implant shell